SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the availability of its BioXp® Select ...
With the validation of the SARS-CoV-2 mRNA vaccines on the global stage, mRNA vaccines and therapeutics are taking the front seat of many biopharma development pipelines. There is an ever-increasing ...
HEIDELBERG, Germany--(BUSINESS WIRE)--AGC Biologics today announced it is partnering with Repair Biotechnologies to tackle one of the world's most persistent health challenges and cause of mortality.
From global vaccines to personalized cancer therapies, mRNA is being considered across several clinical applications, which ultimately creates varying requirements in terms of production scale and ...
BERLIN, Germany--(BUSINESS WIRE)--Vernal Biosciences, a leading Contract Development and Manufacturing Organization (CDMO) specializing in mRNA and LNP manufacturing, proudly announces its ...
MAINZ, Germany, February 2, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced construction completion of the Company’s first proprietary plasmid DNA manufacturing facility ...
mRNA innovation is one of the most exciting and impactful areas of healthcare globally today. A process that has increasingly expansive application potential in treating diseases or functioning as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback